Dear colleagues, As you know, 2019 is an exciting and critical year as we start preparations to launch our first-in-class HIF-PHI, roxadustat and many of us are busy gearing up for next week’s 56th ERA-EDTA conference in Budapest, where we have a significant presence. This year’s major medical priority is to raise awareness of CKD-associated anaemia – communicating the severity of its impact on patients, and the difficulties with current treatment options. Our booth and symposium will help us do this.     During the conference, we’ll also hold an advisory board to gain critical insight that will help us pin down our launch strategy. We look forward to seeing many of you in Budapest, but for those who can’t make it, we’ll be sure to keep you in the loop with essential learnings and take-aways. Stay tuned! Ayesha, Gino, Richard, Najib, Jane, Christine